INS and metabolic dysfunction-associated steatotic liver disease: Beside the presence of the metabolic syndrome and type 2 diabetes and fasting serum insulin, raised AST levels and AST/ALT ratio are often used as independent predictors of liver fat and NAFLD (Kotronen et al., 2009).